Luca Benatti: CEO of EryDel
Luca Benatti, CEO of EryDel, shares his thoughts with BioBoss host John Simboli about leadership in biopharma and how EryDel is working to develop specialized therapies for the treatment of rare diseases by using the patient’s own blood.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.